-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Late-Breaking Abstracts Session

Late-Breaking Abstracts Program: General Sessions
Tuesday, December 12, 2017: 7:30 AM-9:00 AM
Bldg C, Lvl 1, Hall C2-C3 (Georgia World Congress Center)
Adam Cuker, MD, MS, University of Pennsylvania and Laurie H. Sehn, MD, MPH, British Columbia Cancer Agency
Cuker: Spark Therapeutics: Research Funding; T2 Biosystems: Research Funding. Sehn: Amgen: Consultancy, Honoraria; Seattle Genetics: Consultancy, Honoraria; Celgene: Consultancy, Honoraria; Janssen: Consultancy, Honoraria; Abbvie: Consultancy, Honoraria; Roche/Genentech: Consultancy, Honoraria.
This highly anticipated session highlights the Program Committee's selections of the highest-impact abstracts, featuring substantive, novel, and groundbreaking data that were not available by the general abstract submission deadline and would otherwise not be presented at the ASH annual meeting.

Marie Scully, MD1*, Spero R Cataland, MD2, Flora Peyvandi, MD, PhD3, Paul Coppo4*, Paul Knöbl, MD, PhD5*, Johanna A. Kremer Hovinga, MD6*, Ara Metjian, MD7, Javier de la Rubia, MD8*, Katerina Pavenski, MD9, Filip Callewaert, PhD10*, Debjit Biswas, PhD10*, Hilde De Winter, MD11* and Robert K. Zeldin, MD12*

1Department of Haematology, University College London Hospitals NHS Trust, London, United Kingdom
2Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
3Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico; University of Milan, Milano, Italy
4Department of Hematology, Saint-Antoine University Hospital, Paris, France
5Department of Medicine 1, Division of Hematology and Hemostasis, Vienna University Hospital, Vienna, Austria
6University Clinic of Hematology and Central Hematology Laboratory, Bern University Hospital, Inselspital, Bern, Switzerland
7Division of Hematology, Duke University School of Medicine, Durham, NC
8Hematology Department, Universidad Católica de Valencia Hospital Dr. Peset, Valencia, Spain
9Department of Laboratory Medicine and Pathobiology, St. Michael's Hospital/Research Institute, Toronto, ON, Canada
10Clinical Development, Ablynx NV, Zwijnaarde, Belgium
11Clinical Development, Ablynx NV, Zwijnaarde, Oost-Vlaanderen, Belgium
12Chief Medical Officer, Ablynx NV, Zwijnaarde, Belgium

John F Seymour, MBBS, PhD1, Thomas J. Kipps, MD2, Barbara F. Eichhorst, MD3*, Peter Hillmen, MBChB, FRCP, FRCPath, PhD 4, James M. D'Rozario, MBBS FRACP FRCPA5, Sarit Assouline, MD6, Carolyn Jane Owen, MD, FRCPC7, John Gerecitano, MD, PhD8, Tadeusz Robak, MD, PhD9, Javier De la Serna, MD10*, Ulrich Jaeger, MD11*, Guillaume Cartron, MD, PhD12*, Marco Montillo, MD13, Rod Humerickhouse, MD, PhD14*, Elizabeth Punnoose, PhD15*, Yan Li, PhD16*, Michelle Boyer, PhD17*, Kathryn Humphrey, BSc18*, Mehrdad Mobasher, MD, MPH15 and Arnon P. Kater, MD19

1Peter MacCallum Centre & Royal Melbourne Hospital, Melbourne, Australia
2University of California School of Medicine, San Diego, CA
3University Hospital Cologne, Cologne, Germany
4St. James's University Hospital, Leeds, United Kingdom
5The John Curtin School of Medical Research, Australian National University, Canberra, Australia
6Segal Cancer Center, Lady Davis Institute, Jewish General Hospital, Montreal, QC, Canada
7Departments of Medicine and Oncology, University of Calgary, Calgary, AB, Canada
8Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY
9Department of Hematology, Medical University of Lodz and Copernicus Memorial Hospital, Lodz, Poland
10Hospital Universitario 12 de Octubre, Madrid, Spain
11Dept. of Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria
12Department of Hematology, CHU Montpellier, Montpellier, France
13Department of Onco-Hematology, Division of Hematology, Niguarda Cancer Center, Niguarda Hospital, Milan, Italy
14AbbVie Inc., North Chicago, IL
15Genentech, Inc., South San Francisco, CA
16Genentech Inc., South San Francisco, CA
17F. Hoffmann-La Roche, Ltd., Welwyn Garden City, United Kingdom
18F-Hoffmann-La Roche Ltd., Welwyn Garden City, United Kingdom
19Academic Medical Center, Amsterdam, and HOVON CLL-WG, Amsterdam, Netherlands

Christine Bellanné-Chantelot, PharmD, PhD1,2*, Caroline Marty, PhD1*, Barbara Schmaltz-Panneau, PhD1*, Odile Fenneteau, MD3*, Isabelle Callebaut, PhD4*, Séverine Clauin5*, Aurélie Docet5*, Gandhi Damaj, MD6, Thierry Leblanc, MD7*, Isabelle Pellier, MD8*, Cécile Stoven, MD9*, Sylvie Souquere, PhD10*, Iléana Antony-Debre, PhD11*, Blandine Beaupain, MsC12*, Nathalie Aladjidi, MD13*, Vincent Barlogis, MD14*, Frederic Bauduer, MD, PhD15*, Philippe Bensaid, MD16*, Odile Boesflug-Tanguy, MD-PhD17*, Claire Berger, MD18*, Yves Bertrand, MD19*, Liana Carausu, MD20*, Claire Fieschi, MD, PhD21*, Claire Galambrun, MD22*, Aline Schmidt, MD23*, Hubert Journel, MD24*, Francoise Mazingue, MD25, Brigitte Nelken, MD26*, Thuan Chong Quah, MD27*, Eric Oksenhendler, MD28*, Marie Ouachee, MD29*, Marlène Pasquet, MD30*, Felipe Suarez, MD, PhD31, Gérard Pierron, PhD32*, William Vainchenker, MD, PhD1*, Isabelle Plo, PhD1* and Jean Donadieu, MD33

1INSERM UMR1170, Gustave Roussy, Villejuif, France
2Département De Genetique, Hôpital Pitié-Salpétrière, AP-HP, Paris, France
3Laboratoire d’Hématologie, Hôpital Robert Debré, APHP, Paris, France
4CNRS UMR7590, Sorbonne Université, Université Pierre et Marie Curie-Paris6-MNHN-IRD-IUC, Paris, France
5Département de Génétique, Hôpital Pitié-Salpétrière, Paris, France
6Service d'Hématologie, CHU Caen, Caen, France
7Service d’Hématologie et Oncologie pédiatrique, Hôpital Robert Debré, AP-HP, Paris, France
8CHU, Angers, France
9Service de Pédiatrie générale, CHU La Réunion, Site du Groupe Hospitalier Sud Réunion, Saint-Pierre, France
10CNRS UMR-9196, Gustave Roussy, Villejuif, France
11Inserm UMR1170, Gustave Roussy, Villejuif, France
12Registre des Neutropénies, Hopital Trousseau, AP-HP, Paris, France
1312. Unité d’Hématologie Pédiatrique, CIC 1401 INSERM CICP, CHU Bordeaux, Bordeaux, France
14Service d'Hématologie pédiatrique, CHU de Marseille Hopital La timone, Marseille, France
15Centre Hospitalier Côte Basque, Bayonne, France
16Service de Pédiatrie, Centre Hospitalier d'Argenteuil, Argenteuil, France
17Service de Neuropédiatrie et des Maladies Métaboliques, Hôpital Robert Debré, AP-HP, Paris, France
18Service d’hémato-oncologie pédiatrique, CHU Saint-Etienne, Saint-Etienne, France
19IHOPe, Lyon, France
20Service d’Hémato-oncologie pédiatrique, CHU Brest, Brest, France
21Service d’Immunologie clinique, Hôpital Saint-Louis, AP-HP, Paris, France
22Service d'Hématologie pédiatrique, CHU La Timone, Marseille, France
23Service d’Hématologie, CHU Angers, Angers, France
24Département de Génétique, Hôpital Bretagne-Atlantique, Vannes, France
25Service d’Hémato-oncologie pédiatrique, Hopital Jeanne de Flandre Chru de Lille, Lille, France
26Service d’Hémato-oncologie pédiatrique, CHU Hôpital Jeanne De Flandre, Lille, France
27Department of Pediatrics, National University hospital, Singapore, Singapore
28Service d'Immunologie Clinique, Hopital Saint-Louis, AP-HP, Paris, France
29IHOPE, Institut d'hématologie oncologie Pédiatrique, Lyon, France
30Service d’Hémato-oncologie pédiatrique, CHU de Toulouse, Toulouse, France
31Service d'Hématologie adultes, Hôpital Universitaire Necker-Enfants Malades, AP-HP, INSERM UMR 1163 et CNRS ERL 8254, Institut Imagine, Sorbonne Paris Cité, Université Paris Descartes, Paris, France
32Gustave Roussy, CNRS UMR-9196, VILLEJUIF, France
33Service d'Hémato-Oncologie Pédiatrique, Hopital Trousseau, AP-HP, Paris, France

Maria-Victoria Mateos, MD, PhD1, Meletios A. Dimopoulos2, Michele Cavo, MD3*, Kenshi Suzuki4*, Andrzej J. Jakubowiak, MD5, Stefan Knop, MD6*, Chantal Doyen, MD7, Paulo Lucio8*, Zsolt Nagy, MD, PhD9*, Polina Kaplan10*, Ludek Pour, Doc, MD, PhD11*, Mark Cook, MBChB, PhD12, Sebastian Grosicki, MD, PhD13, Andre H Crepaldi, MD14*, Anna Marina Liberati15*, Philip Campbell, MBBS, FRACP, FRCPA16, Tatiana Shelekhova17*, Sung-Soo Yoon, MD, PhD18*, Genadi Iosava19*, Tomoaki Fujisaki, MD20*, Mamta Garg, MD21*, Christopher Chiu, PhD22, Jianping Wang23*, Robin Carson, MD, BA24, Wendy Crist, BA22*, William Deraedt25*, Marie Nguyen23*, Ming Qi22* and Jesus F. San-Miguel, MD26

1University Hospital of Salamanca/IBSAL, Salamanca, Spain
2National and Kapodistrian University of Athens, Athens, Greece
3Institute of Hematology Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy
4Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan
5University of Chicago Medical Center, Chicago, IL
6Würzburg University Medical Center, Würzburg, Germany
7Université catholique de Louvain, CHU UCL Namur, Namur, Belgium
8Champalimaud Foundation, Lisbon, Portugal
9Semmelweis Egyetem, Budapest, Hungary
10Dnepropetrovsk City Clinical Hospital #4, Dnepropetrovsk, Ukraine
11Department of Internal Medicine, Haematooncology and Oncology, University Hospital Brno, Brno, Czech Republic
12University Hospitals Birmingham NHS Trust, Birmingham, United Kingdom
13Department of Cancer Prevention, School of Public Health, Silesian Medical University in Katowice, Katowice, Poland
14Clinica de Tratamento E, Cuiaba, Brazil
15Azienda Ospedaliera "Santa Maria, Terni, Italy
16Andrew Love Cancer Centre, Geelong, Australia
17Clinic of Professional Pathology, Saratov, RUS
18Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea, Republic of (South)
19LTD "Medinvent" Institute of Health, Tbilisi, Georgia
20Matsuyama Red Cross Hospital, Matsuyama, Japan
21Leicester Royal Infirmary – Haematology, Leicester, United Kingdom
22Janssen Research & Development, Spring House, PA
23Janssen Research & Development, Raritan, NJ
24Janssen Biotech, Horsham, PA
25Janssen Research & Development, Beerse, Belgium
26Clínica Universidad de Navarra-CIMA, IDISNA, Pamplona, Spain

Mojca Jongen-Lavrencic, MD, PhD1, Tim Grob, MD1*, Francois G. Kavelaars1*, Adil S.A. Al Hinai1*, Annelieke Zeilemaker1*, Claudia A.J. Erpelinck-Verschueren1*, Yvette Norden2*, Rosa Meijer, PhD2*, Bart J. Biemond, MD, PhD3*, Carlos Graux4*, Marinus van Marwijk Kooij, MD, PhD5*, Markus G. Manz, MD6, Thomas Pabst, MD, PhD7, Violaine Havelange, MD, PhD8*, Jakob R. Passweg, MD, PhD9*, Gert J. Ossenkoppele, MD, PhD10, Gerrit Jan Schuurhuis, PhD10*, Mathijs A. Sanders, PhD1*, Bob Löwenberg, MD, PhD1 and Peter J.M. Valk, PhD1

1Department of Hematology, Erasmus University Medical Center, Rotterdam, Netherlands
2HOVON Data Center, Erasmus University, Rotterdam, Netherlands
3Hematology, Academic Medical Center, Amsterdam, Netherlands
4Université catholique de Louvain, CHU UCL Namur (site Godinne), Godinne, Belgium
5Isala Hospital, Zwolle, Netherlands
6Department of Hematology and Oncology, University and University Hospital Zurich, Zurich, Switzerland
7Department of Medical Oncology, Inselspital, University Hospital and University of Bern, Bern, Switzerland
8St. Luc, Bruxelles, Belgium
9Division of hematology, University Hospital Basel, Basel, Switzerland
10Cancer Center Amsterdam, Department of Hematology, VU University Medical Center, Amsterdam, Netherlands

Gary E. Raskob, PhD1, Nick Van Es, MD2*, Peter Verhamme, MD, PhD3*, Marc Carrier, MD4, Marcello Di Nisio, MD5*, David A. Garcia, MD6, Michael A. Grosso, MD7*, Ajay K. Kakkar, MBBS8, Michael J. Kovacs, MD9, Michele F. Mercuri, MD, PhD, FAHA7*, Guy Meyer, MD10*, Annelise Segers, MD11*, Minggao Shi, PhD7*, Tzu-Fei Wang, MD12, Erik Yeo, MD, FACP, FRCPC13, George Zhang, PhD7*, Jeffrey I. Zwicker, MD14, Jeffrey I. Weitz, MD15 and Harry R. Büller, MD, PhD2*

1College of Public Health, University of Oklahoma College of Public Health, Oklahoma City, OK
2Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands
3Department of Vascular Medicine and Haemostasis, University Hospitals Leuven, Leuven, Belgium
4Ottawa Hospital Research Institute, Ottawa, ON, Canada
5Department of Medicine and Ageing Sciences, "G. D'Annunzio" University of Chieti-Pescara, Chieti, Italy
6Department of Medicine, Division of Hematology, University of Washington, Seattle, WA
7Daiichi Sankyo Pharma Development, Basking Ridge, NJ
8Thrombosis Research Institute, London, United Kingdom
9London Health Sciences Center -Victoria Hospital, London, ON, Canada
10Department of Respiratory Disease, Hôpital Européen Georges Pompidou, Universite Paris Descartes, Paris, France
11Itreas Academic Research Organization, Amsterdam, Netherlands
12Division of Hematology, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH
13University Health Network, University of Toronto, Toronto, ON, Canada
14Division of Hematology - Oncology, Beth Israel Deaconess Medical Center,Harvard Medical School, Boston, MA
15McMaster University, and the Thrombosis and Atherosclerosis Research Institute, Hamilton, ON, Canada

See more of: Late-Breaking Abstracts
See more of: General Sessions